GlassScriptPhysician profile
Janice E Cartwright
NPI 1245896554
$3,329.32
in general payments reported to CMS, 2019-2025
22 companies · $1,285 in 2025
The $1,285 reported for 2025 was more than what 89% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $307 · 2022: $352 · 2023: $683 · 2024: $703 · 2025: $1,285.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,184 · Travel and Lodging: $486.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,184.49 |
| Travel and Lodging | $486.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,232.93 | 2022-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Impulse Dynamics (USA) INC. | $341.64 | 2023-2025 | Optimizer, Optimizer |
| Boston Scientific Corporation | $317.70 | 2024-2025 | Farapulse, Watchman Access System |
| Actelion Pharmaceuticals US, INC. | $297.29 | 2023-2025 | Uptravi, Opsumit, Opsynvi |
| Astrazeneca Pharmaceuticals LP | $239.60 | 2021-2025 | Farxiga, Wainua |
| Merck Sharp & Dohme LLC | $184.02 | 2022-2024 | Verquvo |
| Kestra Medical Technology Services, INC. | $119.38 | 2025 | Assure Wcd |
| Glaxosmithkline, LLC. | $108.03 | 2021 | |
| Lilly USA, LLC | $106.38 | 2021 | |
| Pfizer INC. | $91.04 | 2023-2025 | |
| Abiomed | $39.50 | 2025 | |
| Kiniksa Pharmaceuticals International, Plc | $36.78 | 2024 | Arcalyst |
| Novartis Pharmaceuticals Corporation | $30.98 | 2024 | |
| Novo Nordisk INC | $28.08 | 2025 | Wegovy |
| Scpharmaceuticals INC. | $27.77 | 2023 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $24.27 | 2025 | Nimbl, Flexitouch Plus |
| American Regent | $23.61 | 2025 | Injectafer |
| Eisai INC. | $21.76 | 2022 | |
| Cvrx, INC. | $20.83 | 2024 | Barostim Neo System |
| Myriad Genetic Laboratories, INC. | $20.39 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $14.88 | 2024 | Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $2.46 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janice Cartwright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.